SCHEMBL4497861

SCHEMBL4497861

O=C(O)c1cccc(CNc2ccccc2Cl)c1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 5/20 0.75
PPM1D O15297 1/20 0.57
HIF1A Q16665 1/20 0.57
NPC1 O15118 2/20 0.55
RAB9A P51151 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
HPGD P15428 2/20 0.55
LMNA P02545 1/20 0.55
MITF O75030 1/20 0.55
TP53 P04637 1/20 0.55
XBP1 P17861 1/20 0.55
NFKB1 P19838 1/20 0.55
NFKB2 Q00653 1/20 0.55
RELA Q04206 1/20 0.55
HDAC8 Q9BY41 2/20 0.53
HDAC6 Q9UBN7 2/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
KDM4E B2RXH2 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22469681 0.86 MRGPRX4 (1.00) MRGPRX4PPM1DHIF1AMEN1KMT2A
SCHEMBL31568452 0.86 MRGPRX4 (1.00) MRGPRX4PPM1DHIF1AMEN1KMT2A
SCHEMBL14420823 0.82 MRGPRX4 (0.59) MRGPRX4PPM1DHIF1AHPGDHDAC8
SCHEMBL14420722 0.82 PPM1D (0.60) MRGPRX4PPM1DHIF1AHPGDHDAC8
SCHEMBL4509041 0.81 SENP1 (0.53) MRGPRX4HIF1ANPC1RAB9ASMN1; SMN2
SCHEMBL22480951 0.80 MRGPRX4 (0.71) MRGPRX4
SCHEMBL1287947 0.80 HIF1A (0.83) MRGPRX4HIF1ANPC1RAB9AKMT2A
SCHEMBL2316630 0.79 HSD17B10 (0.59) MEN1KMT2AHPGDHDAC8HDAC6
SCHEMBL1841502 0.78 MAPT (0.56) MRGPRX4PPM1DHIF1ARAB9AMEN1
SCHEMBL11511610 0.78 MRGPRX4 (0.52) MRGPRX4KMT2ALMNAHDAC6HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104837828-B It is used as the phenylethyl pyridine derivate of PDE4 inhibitor 奇斯药制品公司 2017-07-18 CN disclosed
CN-104837828-A Phenylethylpyridine derivatives as PDE4-inhibitors CHIESI FARMA SPA 2015-08-12 CN disclosed
US-20090325956-A1 Aromatic amine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325956-A1 Aromatic amine derivative and use thereof SCD, SCD5, SMS MRGPRX4 1550/4885PPM1D 4471/4885HIF1A 2069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.